Lenetix Medical Screening Laboratory Receives California Genetic Testing Permit
Posted on: Wednesday, 9 May 2007, 15:00 CDT
Lenetix Medical Screening Laboratory, Inc. today announced at the 55th Annual American College of Obstetricians and Gynecologists (ACOG) Meeting that it has been granted a clinical laboratory permit by the State of California. Lenetix Medical Screening Laboratory is a New York-based provider of rapid genetic risk assessment tools and diagnostic tests for clinicians worldwide, and is a key partner of Sequenom Inc. (NASDAQ: SQNM), a San Diego-based company that is developing a portfolio of non-invasive prenatal diagnostics. The notification means that Lenetix is now permitted to receive clinical samples from clients residing in California.
"The opportunity that this permit brings to Lenetix is immeasurable," said Leonard Kellner, President of Lenetix. "Establishing a presence in California will allow us to build a strong customer base in anticipation of establishing a full-service genetics laboratory serving our clients on the West Coast. Our goal is to open a facility in California."
"We are very pleased that Lenetix has been granted this permit to expand its business operations to include the state of California," said Harry Stylli, Ph.D., President and Chief Executive Officer of Sequenom. "The granting of this permit provides the potential for Lenetix to geographically expand its market reach with Sequenom's prenatal diagnostic technology. Lenetix is our first clinical licensee and is scheduled to launch its 'home brew' application for non-invasive prenatal testing for RHD incompatibility this year."
About Lenetix
Founded in 2001, Mineola, NY-based Lenetix is a privately owned provider of innovative technologies focused on diagnostic testing, including prenatal diagnostics, and risk assessment for genetic disease. Lenetix brings more than 27 years' experience developing new and innovative tests that are used by clinicians worldwide. The scientific team at Lenetix is well known for its ability to commercialize new technologies. It is recognized for its translational clinical research and integration of high quality clinical laboratory genetics services within medical centers, universities, and the private sector.
Source: Business Wire
Related Articles
- Roche Introduces New Automated Clinical Laboratory System for CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae
- California Grants SeqWright License to Operate as a Clinical Laboratory
- deCODE Receives California Clinical Laboratory License
- Ikonisys Receives CMS Registration to Establish Clinical Laboratory for Proprietary, Rare-Cell Based Tests
- Provista Life Sciences Announces the Opening of Its Clinical Laboratory - Provista Diagnostics (PDx)
- Clinical Laboratory Analysis Is One of the Most Important Sections of Medical Care Which Is a Significant Reason to Get a Hold of Clinical Laboratory Testing Volume 2: Business Strategies
- This Clinical Laboratory Testing Market Overview Provides the Information and Analysis You Need to Gain an Understanding of the Clinical/Diagnostic Testing Market and the Trends Which Affect It
- Frost & Sullivan Acknowledges Access Genetics' Superior Technology Innovation in Medical Diagnostics
 |
 |
User Comments (0)
RSS Feeds